FindTrial
Sign In

Rad-path correlation between Sonazoid-enhanced ultrasound and pathology

Comparison between Kupffer phase imaging of Sonazoid-enhanced ultrasound and pathological examination

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007324
Enrollment
100
Registered
2022-05-23
Start date
2022-05-09
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Surgical candidates for focal liver lesions noted on imaging

Exclusion criteria

Exclusion criteria: 1. Poor sonic window for liver 2. Contraindicated to ultrasound contrast agent 3. History of hypersensitivity to ultrasound contrast agent 4. Unsuitable for enrollment due to other reasons

Design outcomes

Primary

MeasureTime frame
Brightness of hepatic parenchyma and focal liver lesion on Sonazoid-enhanced ultrasound;Number and distribution of Kupffer cells on pathology—

Secondary

MeasureTime frame
Brightness of hepatic parenchyma on gadoxetic acid-enhanced MRI—

Countries

Korea, Republic of

Contacts

Public ContactJae Seok Bae

Seoul National University Hospital

baejae@snu.ac.kr+82-2-2072-3107

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026